Skip to main content
SpringerLink
Log in

Principles of Cancer Treatment and Anticancer Drug Development

  • Textbook
  • © 2019

Overview

Authors:
  1. Wolfgang Link

    1. Instituto de Investigaciones Biomédicas “Alberto Sols” (CSIC-UAM), Madrid, Spain

    View author publications

    You can also search for this author in PubMed   Google Scholar

  • Explains in easy-to-understand language, how current medicines against cancer work and how we find new ones for interested readers and students
  • It includes the most updated options to treat cancer and provides a unique insight into the world of modern drug discovery
  • Provides a unique way for teachers and students to teach/learn about basic concepts in biomedical and drug research with simple and comprehensive figures and tables, text boxes.

This is a preview of subscription content, log in via an institution to check access.

Access this book

Log in via an institution
eBook USD 39.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book USD 64.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book USD 69.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Other ways to access

Licence this eBook for your library

Institutional subscriptions

Table of contents (5 chapters)

  1. Front Matter

    Pages i-xiv
    Download chapter PDF

  2. Introduction

    • Wolfgang Link
    Pages 1-6

  3. Cancer Therapy

    • Wolfgang Link
    Pages 7-76

  4. Cancer Drug Resistance

    • Wolfgang Link
    Pages 77-85

  5. Drug Discovery and Development

    • Wolfgang Link
    Pages 87-136

  6. Economic and Social Implications of Modern Drug Discovery

    • Wolfgang Link
    Pages 137-139

  7. Back Matter

    Pages 141-145
    Download chapter PDF
Back to top

Keywords

About this book

This book explains how current medicines against cancer work and how we find new ones. It provides an easy-to-understand overview of current options to treat patients with cancer, which includes Surgery, Radiation therapy, Chemotherapy, Targeted therapy and Immunotherapy. The efficiency of all these treatments is limited by the capacity of cancer cells to escape therapy. This book explains the mechanisms of anti-cancer drug resistance and strategies to overcome it. The discovery and development process of a new drug is detailed beginning with the identification and validation of a therapeutic target, the identification of an inhibitor of the target and its subsequent preclinical and clinical development until its approval by regulatory authorities. Particular emphasis has been given to specific aspects of the development process including lead generation and optimization, pharmacokinetics, ADME analysis, pharmacodynamics, toxicity and efficacy assessment, investigational new drug (IND)and new drug application (NDA) and the design of clinical trial and their phases. The book covers many aspects of modern personalized oncology and discusses economic aspects of our current system of developing new medicines and its impact on our societies and on future drug research.

The author of this book, Dr. Link counts with more than 20 years of experience in biomedical research reflected in numerous publications, patents and key note and plenary presentations at international conferences. Interested readers, students and teachers should read this book as it provides a unique way to learn/teach about basic concepts in oncology and anti-cancer drug research.

Reviews

“‘Principles of Cancer Treatment and Anticancer Drug Development’ provides a welcome introduction to the treatment of cancer and the development of new cancer therapies. Every clinical researcher would benefit from a basic understanding of the treatment and research context of cancer clinical research studies.” (Norman M. Goldfarb, Journal of Clinical Research Best Practices, Vol. 16 (2), February, 2020)

Authors and Affiliations

  • Instituto de Investigaciones Biomédicas “Alberto Sols” (CSIC-UAM), Madrid, Spain

    Wolfgang Link

About the author

Dr. Wolfgang Link is an Assistant Professor at the Universisty of Algarve in the Department of Biomedical Sciences and Medicine. He is also Head of Oncobiology at the Center for Biomedical Research (CBMR).

Bibliographic Information

Publish with us

Policies and ethics

Back to top

Search

Navigation